Further evidence for TRIB2 as a modulator of tumorigenic activity comes from liver cancer cells, where the overexpression of TRIB2 was shown to negatively regulate WNT signaling activity, leading to inhibition of cell growth [19]. This evidence concerns the gene TRIB2 and liver cancer.